Distribution of antimicrobial consumption by antimicrobial group

DAMC02
 
Distribution of Antibacterials for systemic use (ATC group J01) in the community (primary care sector) in Austria, reporting year 2016
Distribution of Antibacterials For Systemic Use (ATC group J01) in the community (primary care sector) in Austria, reporting year 2016
Antimicrobial class
  
ATC Code
Name
DDD per 1000 inhabitants and per day
Percent
J01A
Tetracyclines
0.86
6.4%
J01B
Amphenicols
0.00
0.0%
J01C
Beta-lactam antibacterials, penicillins
6.53
49.1%
J01D
Other beta-lactam antibacterials
1.41
10.6%
J01E
Sulfonamides and trimethoprim
0.20
1.5%
J01F
Macrolides, lincosamides and streptogramins
2.74
20.6%
J01G
Aminoglycoside antibacterials
0.01
0.1%
J01M
Quinolone antibacterials
1.20
9.0%
J01R
Combinations of antibacterials
0.00
0.0%
J01X
Other antibacterials
0.34
2.6%
Total
13.3
100.0%
References:
1. Sub-classification of macrolides:
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45.
2. Sub-classification of quinolones
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi47-56.
3. Classification of antivirals for systemic use based on their main indication
Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, et al. European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother. 2011 Aug;66(8):1897-905.
General comments for comparison of antimicrobial consumption data from different countries and/or years:
Total care includes data both from the hospital sector and community (primary care sector) and overestimates the figures when used for reporting for the community sector.
Some countries report reimbursement data that do not include consumption of antimicrobials obtained without prescription and other non-reimbursed courses.
For more information please see the report "Data source overview of antimicrobial consumption"
This report has been generated from ESAC-Net data submitted to TESSy, The European Surveillance System on 2017-11-19. The report reflects the state of submissions in TESSy as of 2017-11-18 at 20:00